Standardised mAb production research provides ‘benchmark’ for biosimilars
NIST has progressed beyond producing the world’s first standardised mAb to make public its production methods.
Archives for August 22, 2018
US FDA approves expanded label for Merck’s Keytruda as first-line treatment for NSCLC
The US FDA has approved an expanded label for Merck’s Keytruda in combination with pemetrexed and platinum chemotherapy.